KEY FINDINGS The Europe protein expression market is projected to register growth, showcasing a CAGR of 10.57% during the forecast period, 2019-2028. The increasing disposable income, and the ease in availability of the protein structure database, are among the primary factors pushing the market growth. The expanding graph of the geriatric population, and the presence of key contract research organizations that facilitate the research of protein expression, are the other factors contributing to market growth. Also, there is an increasing demand for biologics as a result of the prevalence of diabetes in the region.
MARKET INSIGHTS The Europe protein expression market growth analysis entails the market assessment of Germany, France, Russia, Italy, the United Kingdom, Poland, Belgium, and the rest of Europe.Germany has been witnessing a high number of protein research activities, where research is conducted on a large scale basis in pharmaceuticals, universities, and biotech companies.
The University of Copenhagen and Novo Nordisk work alongside in the proteomics research field.Such activities and efforts are said to contribute to overall market growth.
The research institutions of the country are major end-users of protein engineering services, having long-term collaborations with many pharmaceutical companies.They are engaged in the full characterization of recombinant and natural proteins utilized in toxic proteomics and human therapy.
The application of protein engineering has increased with laboratory automation and high throughput screening in R&D centers. Also, the prevailing diseases are set to aid the market growth further, along with the rising protein engineering research.
COMPETITIVE INSIGHTS Qiagen N.V., Thermo Fisher Scientific Inc, Takara Holdings Inc, Promega Corporation, Merck KGaA, are among the prominent companies operating in the market.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period. The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting...
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing...
176 pages •
By Global Industry Analysts
• Apr 2021
- Global Healthcare Contract Research Organization (CRO) Market to Reach $54.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Healthcare Contract Research Organization (CRO) estimated at US$38.4 Billion in the year 2020, is projected to reach a revised size of US$54.7 Billion by 2027,...
Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028 Nordic Regulatory Affairs Market Growth & Trends The Nordic regulatory...
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
The global high-throughput screening market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period. The growth in this market is primarily attributed to increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.